kabutan

CellSeed Inc.(7776) Summary

7776
TSE Growth
CellSeed Inc.
288
JPY
-4
(-1.37%)
Apr 3, 3:30 pm JST
1.80
USD
Apr 3, 2:30 am EDT
Result
PTS
outside of trading hours
288.5
Apr 3, 11:57 pm JST
Summary Chart Historical News Financial Result
PER
PBR
8.82
Yield
ー%
Margin Trading Ratio
47,560.00
Stock Price
Apr 3, 2026
Opening Apr 3, 9:00 am
296 JPY 1.85 USD
Previous Close Apr 2
292 JPY 1.83 USD
High Apr 3, 9:04 am
298 JPY 1.86 USD
Low Apr 3, 12:40 pm
286 JPY 1.79 USD
Volume
446,900
Trading Value
0.13B JPY 0.81M USD
VWAP
288.98 JPY 1.81 USD
Minimum Trading Value
28,800 JPY 180 USD
Market Cap
0.01T JPY 0.07B USD
Number of Trades
372
Liquidity & Number of Trades
As of Apr 3, 2026
Liquidity
High
1-Year Average
1,087
1-Year High Apr 10, 2025
12,100
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 27, 2026 0 3,590,800
Mar 19, 2026 0 3,939,800
Mar 13, 2026 0 3,863,500
Mar 6, 2026 1,100 3,794,800 3449.82
Feb 27, 2026 1,100 3,716,100 3378.27
Company Profile
CellSeed Inc. is a biotech venture originating from Tokyo Women's Medical University, primarily focused on cell sheet regenerative medicine and regenerative medicine support.
Sector
Precision Instruments
CellSeed Inc. is based on cell sheet engineering technology and aims to promote the global adoption of cell sheet regenerative medicine. The company operates in two main areas: regenerative medicine support and cell sheet regenerative medicine. In the regenerative medicine support business, CellSeed Inc. conducts research, development, manufacturing, and sales of temperature-responsive cell culture equipment and related products. The cell sheet regenerative medicine business involves the research, development, manufacturing, and sales of cell sheet regenerative medicine products and their applications.